Recombinant Human ADAM8 protein (rFc Tag)

种属

Human

纯度

>70 %, SDS-PAGE

标签

rFc Tag

生物活性

未测试

Cat no : Eg2912

Print datasheet

Synonyms

CD156, CD156a, Cell surface antigen MS2, Disintegrin and metalloproteinase domain-containing protein 8, EC:3.4.24.-



产品信息

纯度 >70 %, SDS-PAGE
内毒素 <0.1 EU/μg protein, LAL method
生物活性
Not tested
来源 HEK293-derived Human ADAM8 protein Ile17-Pro497 (Accession# P78325-1) with a rabbit IgG Fc tag at the C-terminus.
基因ID 101
蛋白编号 P78325-1
预测分子量 78.5 kDa
SDS-PAGE 68-75 kDa and 85-100 kDa, reducing (R) conditions
组分 Lyophilized from 0.22 μm filtered solution in PBS, pH 7.4. Normally 5% trehalose and 5% mannitol are added as protectants before lyophilization.
复溶 Briefly centrifuge the tube before opening. Reconstitute at 0.1-0.5 mg/mL in sterile water.
储存条件
It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
  • Until expiry date, -20℃ to -80℃ as lyophilized proteins.
  • 3 months, -20℃ to -80℃ under sterile conditions after reconstitution.
运输条件 The product is shipped at ambient temperature. Upon receipt, store it immediately at the recommended temperature.

背景信息

ADAM8 (A Disintegrin and Metalloproteinase 8) is also known as CD156a (cluster of differentiation 156a), a transmembrane glycoprotein belonging to the ADAM family of metalloproteinase-disintegrins. Under physiological conditions, its expression is relatively low and dispensable. However, its expression is potently induced by a variety of inflammatory stimuli, including cytokines (e.g., TNF-α, IL-1β, IFN-γ), lipopolysaccharide (LPS), and hypoxic conditions. ADAM8 is significantly expressed in key immune cells within inflammatory and tumor microenvironments. It is found in neutrophils), macrophages, and natural killer (NK) cells. In neutrophils, it is crucial for migration and transmigration. ADAM8 is also highly overexpressed in some aggressive cancers, including pancreatic ductal adenocarcinoma (PDAC), high expression levels of ADAM8, a metalloprotease disintegrin, are correlated with poor clinical outcome.

参考文献:

1.Kuo, Paul C et al. Cancers vol. 15,12 (2023). 2.Cuffaro, Doretta et al. ACS medicinal chemistry letters vol. 12,11 (2021): 1787-1793. 3.Zuo, Wenjie et al. Journal of advanced research vol. 73, (2025): 483-499. 4.Schlomann, Uwe et al. Nature communications vol. 6, (2015): 6175.

||
New chat

Able

正在加载,请稍候...